logo
Categories
Join us

Python Senior Developer

What we can offer:

A leadership team with more than half a century of the highest-level pricing and Market Access experience means that Access Infinity is a great place to develop your skills in the field as part of our innovative and growing team.

  • We have a strong training and development programme with 20+ learning modules to give you the best start to your global market access career. These include subject matter training in market access and pricing as well as transferable skills such as project management and presentation writing
  • You will learn the best practices in project management from true leaders in the industry, in a friendly and fun environment
  • Support will always be available from the senior team in an accessible, flat company structure
  • Development opportunities and performance/promotion reviews to accelerate your development
  • We believe in rewarding high performance and offer a generous compensation package
About you:

We seek experienced Python developers to join our fast-growing Digital Solutions team to design, develop and implement ML and AI solutions for our digital products to address the business challenges faced by the Market Access teams of our Pharma customers. We are looking for people who have a proactive, solution-oriented approach, are great at managing their time and strong communicators.

What we are looking for:

Key Responsibilities:

  • Collaborate with cross-functional teams to understand project requirements and objectives
  • Design and develop AI models and algorithms using Python and other relevant technologies
  • Implement AI solutions using Generative AI models
  • Implement machine learning and deep learning techniques to solve complex problems
  • Optimize and fine-tune AI models for performance and scalability
  • Conduct experiments and evaluations to validate the effectiveness of AI solutions
  • Stay updated on the latest advancements in AI and machine learning research
  • Provide technical guidance and support to junior team members as needed
  • Building reusable/extensible code for future use
  • Excellent problem-solving skills and attention to detail
  • Strong communication and teamwork abilities

Technical Skillset:

  • Proven experience as an AI Developer or similar role, with a strong focus on Python development for AI applications.
  • Solid understanding of machine learning and deep learning concepts, including the ability to implement and adapt advanced algorithms and architectures.
  • Proficiency in Python programming with experience in AI libraries and frameworks such as TensorFlow, PyTorch, scikit-learn, Keras, JAX, Hugging Face Transformers, fastai, ONNX, and LangChain for a comprehensive approach to machine learning and language model applications.
  • Demonstrated experience with the full lifecycle of AI model development, including data pre-processing, feature engineering, model training, evaluation, and deployment.
  • Experience in building and deploying Generative AI solutions using LLMs such as OpenAI’s GPT models or Google’s Gemini, with a focus on practical applications.
  • Strong knowledge of cloud computing platforms like AWS, Azure, or Google Cloud Platform, including experience with managing AI workloads and deploying models at scale.
  • Proficiency in RESTful API design, development, and integration, with a focus on connecting AI models with enterprise applications.
  • Experience with NoSQL and Vector databases.
  • Good knowledge of SQL, T-SQL, and stored procedures is a big plus.
  • Familiarity with software development best practices, including agile methodologies, version control systems like Git, and knowledge on continuous integration/continuous deployment (CI/CD) pipelines.

 Qualifications:

  • 3-5 years’ experience as an AI Developer or similar role, with a strong focus on Python development
  • Graduate in Computer Science engineering or a related field
  • Experience with Agile and Waterfall methodologies
  • Superb communication and inter-personal skills
  • Strong documentation skills required.

Please email your CV and cover letter along to careers.india@accessinfinity.com with the role you are applying for as the subject.

Categories
Resources

Nuro brochure

Categories
Resources

Access Hub brochure

Categories
Podcasts

Sharing your market access story and demonstrating value with Biogen’s Adrian Harrington

Categories
Podcasts

Digitalisation of Market Access with Thomas Gilboy and Shravani Madishetti

Categories
Event

ISPOR Europe 2024

ISPOR Europe 2024

Let’s meet at ISPOR Europe 2024

Join us in Barcelona between 17th- 20th November where we’ll be sharing the latest insights and innovations from the Access Infinity team on industry hot topics.

Join us on Day 1, 2:05 pm for our panel discussion:

Metrics that Matter in Market Access Performance Tracking

Moderator:  Ahmed Edathodu, Founding Director, Access Infinity 

Panellists:  

  • Aodan Tynan, Vice President, Global Market Access, Astellas

  • Chris Bidad, Global Head, Access Strategy and Payer Policy, AstraZeneca

  • Robert Palmer, Head of Market Access, Oncology, Boehringer Ingelheim

  • Samia Aly, Executive Director, Value & Access, Innovative Medicines Europe, Novartis

  • Simon Shohet, Vice President, Market Access, International, Amicus Therapeutic

Market access is the bridge between clinical and commercial functions and plays a pivotal role in product launch. Success in market access is defined by the outcome of payer decisions – whether nationally or regionally. 

While measuring global market access performance has been on the agenda for some time, understanding success is becoming a priority at board and leadership level. 

How can market access leaders do it better, so they’re empowered to communicate their team’s success? 

In this this discussion, the panel explore the changing role of market access and the importance of tracking performance as a result. They take a deeper dive into how this can be done, the challenges it presents and how they can be overcome.  

Join the Access Infinity team at RAI Congress Centre Amsterdam 12th – 13th March.

Join us on Day 2, 3:35 pm to hear from our Product Owner on: ​

Three ways AI will impact Market Access in 2024

In this session our Product Owner, Tom Gilboy will share three tangible use cases of AI for Market Access teams that could be ready to go this very year.  He will also share the capabilities Market Access teams need to build to avoid being left behind by the AI revolution. 

Join the Access Infinity team at RAI Congress Centre Amsterdam 12th- 13th March.

Thomas Gilboy

Digital Solutions Product Owner Thomas Gilboy is the Product Owner at Access Infinity for our Market Access Digital Tools. As Product Owner, he leads the product development and leads the product development leads the product development and “blue sky thinking” of what is possible within the digital space for Market Access. Before Access Infinity, Tom worked for 10 years within Market Access in consulting and at ViiV. In consulting Tom delivered over 100 projects covering a broad range of Market Access topics from early pipeline decisions through to end of life cycle planning, across a broad range of therapy areas. At ViiV, Tom covered the successful European Market Access for one of their launching HIV brands.   

Meet Access Infinity's digital team

Keshav Nagaraja

Managing Director

Robert Buckley

Senior Business Development Manager

Russ Leslie

Head of Sales

Louise Bennett

Head of Marketing

 

THOMAS GILBOY​

Product Owner

Louise Bennett

Head of Marketing

 

Ahmed Edathodu

Founding Director

Isabel Rubio

Director

Robert Buckley

Senior Business Development Manager

Thomas Gilboy

Product Owner

Margaret Labban

Product Manager

Best practices in estimating pipeline product prices for early market access teams

It goes without saying that analogues are a great choice for robust evidence because they tell us what’s historically happened to products in similar situations. Of course, there is no perfect analogue that 100% meets your own product, so how do you choose which ones to analyse and review?
There’s much to consider and a lot at stake, not to mention the time pressures you’re facing to answer complex questions, at pace.
So how can early market access professionals take a holistic approach to finding the right analogues in the right time frame?
Our Product Owner Thomas Gilboy explores this at EPA Congress, taking a deeper dive into:
· The analogue analysis challenges faced by today’s early market access teams[LB1]
· How to produce more accurate analysis and evidence to support a product’s launch strategy
· How to pick up the pace of analogue analysis [LB2] so that you can respond rapidly and accurately to enquiries from the [launch?] team

Let’s meet in person

The World EPA Congress 2022 is a great opportunity to share ideas. Block some time for a product demo or chat with our P&MA experts. We look forward to seeing you in Amsterdam.

Meet us at Booth 20.

About Access Infinity

Access Infinity is the world leader of digital transformation in the Pharma Industry. We are a trusted provider of digital platforms and consulting services to leading pharma companies

We come in two flavours

Consulting

The critical support you need to develop a successful value assessment and launch strategy.

Digital products

Time-saving digital solutions that help you launch your brand to the right patients, at the right price, at the right time.

We look forward to meeting you

ISPOR 2024 is a great opportunity to share ideas. Block some time for a product demo or chat with our P&MA experts. We look forward to seeing you in Barcelona.

Categories
Webinar

Winning Market Access Strategies Based on Our 2024 Survey

Categories
News

Access Infinity Joins SME Climate Hub in Commitment to Climate Action

LONDON, UK — 15th March 2024, Access Infinity, an award-winning market access consultancy and digital solutions firm, is pleased to announce its membership in the SME Climate Hub, a global initiative dedicated to empowering small to medium-sized enterprises to take tangible steps towards climate action and resilience building.

Recognising that climate change poses a threat to the economy, nature and society at large, Access Infinity commits to take action immediately in order to:

  • Halve their greenhouse gas emissions before 2030
  • Achieve net zero emissions before 2050
  • Disclose their progress on a yearly basis

In doing so, they are proud to be recognised by the United Nations Race to Zero campaign, and join governments, businesses, cities, regions, and universities around the world that share the same mission. 

Access Infinity’s Partner, Nick Proctor shares his enthusiasm about the company’s new direction: 

"This is an exciting step in Access Infinity's growth. We have made this commitment in recognition that our clients need more than just the project excellence they are used to, they need an environmentally responsible partner too. We are delighted to make this change for our clients, communities and the world we live in."
Nick Proctor
Partner

Through its membership in the SME Climate Hub, Access Infinity seeks to collaborate with like-minded businesses, share best practices, and drive positive change within its industry and beyond.

For more information about Access Infinity and its commitment to climate action, please visit: SME Climate Hub.

About Access Infinity

Access Infinity exists to help pharma companies overcome market access challenges. Founded in 2014, the company began as a consulting firm to guide pharma businesses in developing and implementing effective market access and pricing strategies and continues to be a leader in the space. It has since introduced market-redefining digital tools, NUROTM, Access HubTM and Evidence Library to help market access teams work smarter, faster, and more efficiently with valuable insights at their fingertips.

With offices in London, Hyderabad and Manchester, Access Infinity is experiencing rapid growth as it continues to transform and simplify market access for pharmaceutical organisations globally. Clients include many of the pharmaceutical industry’s leading companies such as Astra Zeneca, GSK and Pfizer. In 2023 Access Infinity received a Bronze Stevie® Award in the Technical Innovation of the Year category for organisations with up to 100 employees. The business was also recognised in GHP magazine’s Healthcare & Pharmaceutical Awards, winning “Most innovative digital pharmaceuticals platform 2023 UK”. 

 
For more information, press only:
Tel: +44 (0)20 4583 5450
Categories
News

Access Infinity Brings Development In-house to Fuel Growth

LONDON, UK — 4th March 2024, Access Infinity, an award-winning market access consultancy and digital solutions firm, today announced it has acquired some of the engineering team of its long-term partner Incepteo, previously responsible for supporting the build of innovative products for Access Infinity. This move follows a strategic transfer agreement with Incepteo, and positions Access Infinity for accelerated growth and enhanced in-house development capabilities.

“This acquisition marks a significant step forward in our journey to deliver cutting-edge solutions to our clients. The Incepteo team has been instrumental in shaping our product portfolio and bringing them on board as full-time employees grants us greater agility and seamless alignment with our long-term vision.”
Keshav Nagaraja
Managing Director, Access Infinity

Also commenting on the acquisition, Founding Director, Shri Rao Mukku said:

“As founders, Ahmed and I are so pleased with this outcome as with the addition of high-quality engineers who have been working with our tools from inception 6 years ago, we are bringing in collectively 60+ years of digital experience in engineering in-house, which is a massive boost to our ability to deliver digital solutions to the market access function.”
Shri Rao Mukku
Founding Director, Access Infinity

The acquired team boasts highly skilled architects, developers, and testers who have played a crucial role in developing Access Infinity’s innovative products. The addition of this talent pool represents a significant milestone in the company’s trajectory, allowing the company to bolster its in-house engineering capabilities to create and deliver industry-leading solutions, propel expansion efforts and foster greater agility and efficiency.

“We're delighted to see our successful partnership with Access Infinity evolve through this team acquisition. Since 2018, Incepteo has proudly supported the conceptualisation and development of Access Infinity’s innovative digital solutions. This transition aligns with our expertise in building, operating, and transferring teams for several of our clients and marks another exciting chapter in Incepteo’s journey.”
Chaithanya Kumar
CEO, Incepteo

About Access Infinity

Access Infinity exists to help pharma companies overcome market access challenges. Founded in 2014, the company began as a consulting firm to guide pharma businesses in developing and implementing effective market access and pricing strategies and continues to be a leader in the space. It has since introduced market-redefining digital tools, NUROTM, Access HubTM and Evidence Library to help market access teams work smarter, faster, and more efficiently with valuable insights at their fingertips.

With offices in London, Hyderabad and Manchester, Access Infinity is experiencing rapid growth as it continues to transform and simplify market access for pharmaceutical organisations globally. Clients include many of the pharmaceutical industry’s leading companies such as Astra Zeneca, GSK and Pfizer. In 2023 Access Infinity received a Bronze Stevie® Award in the Technical Innovation of the Year category for organisations with up to 100 employees. The business was also recognised in GHP magazine’s Healthcare & Pharmaceutical Awards, winning “Most innovative digital pharmaceuticals platform 2023 UK”.

 
For more information, press only:
Tel: +44 (0)20 4583 5450
Categories
Webinar

5 access & pricing questions you can answer in minutes with Nuro